Genetic approaches to craniofacial tissue repair

Annals of the New York Academy of Sciences

Volumn 961, Issue , 2002, Pages 48-57

  Bonadio, Jeffrey ^a   Cunningham, Michael L ^b,c  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Craniofacial skeletal malformation; Gene therapy; Tissue engineering

Indexed keywords

PLASMID VECTOR; RECOMBINANT DNA;

CELL REGENERATION; CELL TRANSPLANTATION; CONFERENCE PAPER; CRANIOFACIAL MALFORMATION; GENE TECHNOLOGY; GENE THERAPY; HUMAN; MOLECULAR GENETICS; TISSUE ENGINEERING; TISSUE REPAIR; WOUND HEALING;

EID: 0036302970     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb03047.x     Document Type: Conference Paper

References (40)

1. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation
2. Tissue engineering: Current state and prospects
3. Establishing an immortalized human osteoprecursor cell line
4. A tissue engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats
5. Tissue engineering via local gene delivery: Update and future prospects for enhancing the technology
6. Transfection of large plasmids in primary human myoblasts
7. Intramuscular plasmid DNA injection can accelerate autoimmune responses
8. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
9. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
10. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
11. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms
12. Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics
13. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics
14. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer
15. Gene therapy for acute diseases
16. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column
17. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle
18. Craniofacial tissue engineering
19. Bone gap healing in the dog using recombinant human bone morphogenetic protein-2
20. Human recombinant BMP-2 in osseous reconstruction of simulated cleft palate defects
21. Long-term evaluation of osseointegrated implants inserted at the time or after vertical ridge augmentation: A retrospective study on 123 implants with 1-5 year follow-up
22. Craniofacial malformations and syndromes
23. Morbidity from bone harvest in major jaw reconstruction: A randomized trial comparing the lateral anterior and posterior approaches to the ilium
24. Failure of bone induction by bone matrix in adult monkeys
25. A clinical and histologic examination in humans of the osseous response to implanted natural bone mineral
26. Bone grafts and biomaterials used as bone grafts substitutes
27. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions
28. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect
29. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappa-β ligand
30. Regulatable systems: Applications in gene therapy and replicating viruses
31. A humanized system for pharmacologic control of gene expression
32. Pharmacologic control of a humanized gene therapy system implanted into nude mice
33. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector
34. A mammalian protein targeted by G1-arresting rapamycin-receptor complex
35. Molecular cloning and overexpression of the human FK506-binding protein FKBP
36. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer
37. Clinical pharmacokinetics of sirolimus
38. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum